List view / Grid view
The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.
1 December 2016 | By Charles River
This webinar details a successful new strategy to identify small molecule therapies to treat protein-destabilizing monogenic disorders...
Support your kinase inhibitor drug discovery programs with the most comprehensive kinase assay menu from DiscoverX’s KINOMEscan screening and profiling services, now with the fastest available turnaround time of 5 days for the ELECT services*...
Novel candidate drug targets for systemic scleroderma were identified using RNAi in phenotypic assays in scleroderma patient-derived fibroblasts...
4 August 2016 | By Bio-Rad Laboratories
The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples...
4 August 2016 | By Bio-Rad Laboratories
The Bio-Rad automated S3e™ Cell Sorter allows you to perform simple 1–4 colour sorts in less than 30 minutes and greatly enhances your experimental success...
28 July 2016 | By IntelliCyt Corporation
Robust mix and read kits for cell- and bead-based screening applications...
28 June 2016 | By Merck KGaA
EMD Millipore is continually developing and refining tools and technologies for the study of neuroscience. Researchers can count on our comprehensive portfolio of dependable, high-quality solutions for elucidating questions related to neuroscience...
15 June 2016 | By Merck KGaA
We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
2 June 2016 | By Merck KGaA
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research...
10 May 2016 | By Merck KGaA
Complete product portfolio for the study of cell structure, intracellular signaling, extracellular environment, and cellular migration and invasion...
28 April 2016 | By Merck KGaA
Each of EMD Millipore’s ChIPAb+™ and RIPAb+™ antibodies are validated and tested for ChIP and RNA immunoprecipitation (RIP)...
12 April 2016 | By Merck KGaA
As a leading provider of antibodies for cell signaling research, EMD Millipore is advancing life science research and therapeutic development...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
1 March 2016 | By Merck KGaA
With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analysing all the hallmarks of cancer...
